Treatment Recommendations for the Use of Antipsychotics for Aggressive Youth (TRAAY). Part I: A review

Sarah B. Schur, Lin Sikich, Robert L Findling, Richard P. Malone, M. Lynn Crismon, Albert Derivan, James C. MacIntyre, Elizabeth Pappadopulos, Laurence Greenhill, Nina Schooler, Kimberly Van Orden, Peter S. Jensen

Research output: Contribution to journalArticle

Abstract

Objectives: To review the evidence for the safety and efficacy of nonpharmacological and pharmacological treatments for aggression in children and adolescents. Method: Medline and PsycINFO searches (1990-present) were conducted for double-blind, placebo-controlled studies of atypical antipsychotics for aggression and for literature on the use of other pharmacological agents and psychosocial interventions for aggression. Case reports and adult literature regarding the safety of atypical antipsychotics were used where controlled data for youth were lacking. Results: Controlled data on the treatment of aggression in youth is scarce. Psychosocial interventions may be effective alone or in combination with pharmacological treatments. Psychotropic agents (e.g., stimulants, mood stabilizers, β-blockers) have also been shown to have limited efficacy in reducing aggression. Antipsychotics, particularly the atypical antipsychotics, show substantial efficacy in the treatment of aggression in selected pediatric populations. Atypical antipsychotics are generally associated with fewer extrapyramidal symptoms than are typical antipsychotics. Conclusions: Psychosocial interventions and atypical antipsychotics are promising treatments for aggression in youth. Double-blind studies should examine the safety and efficacy of atypical antipsychotics compared to each other and to medications from other classes, the efficacy of specific medications for different subtypes of aggression, combining various psychotropic medications, optimal dosages, and long-term safety.

Original languageEnglish (US)
Pages (from-to)132-144
Number of pages13
JournalJournal of the American Academy of Child and Adolescent Psychiatry
Volume42
Issue number2
DOIs
StatePublished - Feb 2003
Externally publishedYes

Fingerprint

Aggression
Antipsychotic Agents
Safety
Pharmacology
Therapeutics
Double-Blind Method
Placebos
Pediatrics
Population

Keywords

  • Aggression
  • Antipsychotics
  • Psychosocial treatments

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Developmental and Educational Psychology

Cite this

Treatment Recommendations for the Use of Antipsychotics for Aggressive Youth (TRAAY). Part I : A review. / Schur, Sarah B.; Sikich, Lin; Findling, Robert L; Malone, Richard P.; Crismon, M. Lynn; Derivan, Albert; MacIntyre, James C.; Pappadopulos, Elizabeth; Greenhill, Laurence; Schooler, Nina; Van Orden, Kimberly; Jensen, Peter S.

In: Journal of the American Academy of Child and Adolescent Psychiatry, Vol. 42, No. 2, 02.2003, p. 132-144.

Research output: Contribution to journalArticle

Schur, SB, Sikich, L, Findling, RL, Malone, RP, Crismon, ML, Derivan, A, MacIntyre, JC, Pappadopulos, E, Greenhill, L, Schooler, N, Van Orden, K & Jensen, PS 2003, 'Treatment Recommendations for the Use of Antipsychotics for Aggressive Youth (TRAAY). Part I: A review', Journal of the American Academy of Child and Adolescent Psychiatry, vol. 42, no. 2, pp. 132-144. https://doi.org/10.1097/00004583-200302000-00007
Schur, Sarah B. ; Sikich, Lin ; Findling, Robert L ; Malone, Richard P. ; Crismon, M. Lynn ; Derivan, Albert ; MacIntyre, James C. ; Pappadopulos, Elizabeth ; Greenhill, Laurence ; Schooler, Nina ; Van Orden, Kimberly ; Jensen, Peter S. / Treatment Recommendations for the Use of Antipsychotics for Aggressive Youth (TRAAY). Part I : A review. In: Journal of the American Academy of Child and Adolescent Psychiatry. 2003 ; Vol. 42, No. 2. pp. 132-144.
@article{10873f59573f410c91fda1bae1841419,
title = "Treatment Recommendations for the Use of Antipsychotics for Aggressive Youth (TRAAY). Part I: A review",
abstract = "Objectives: To review the evidence for the safety and efficacy of nonpharmacological and pharmacological treatments for aggression in children and adolescents. Method: Medline and PsycINFO searches (1990-present) were conducted for double-blind, placebo-controlled studies of atypical antipsychotics for aggression and for literature on the use of other pharmacological agents and psychosocial interventions for aggression. Case reports and adult literature regarding the safety of atypical antipsychotics were used where controlled data for youth were lacking. Results: Controlled data on the treatment of aggression in youth is scarce. Psychosocial interventions may be effective alone or in combination with pharmacological treatments. Psychotropic agents (e.g., stimulants, mood stabilizers, β-blockers) have also been shown to have limited efficacy in reducing aggression. Antipsychotics, particularly the atypical antipsychotics, show substantial efficacy in the treatment of aggression in selected pediatric populations. Atypical antipsychotics are generally associated with fewer extrapyramidal symptoms than are typical antipsychotics. Conclusions: Psychosocial interventions and atypical antipsychotics are promising treatments for aggression in youth. Double-blind studies should examine the safety and efficacy of atypical antipsychotics compared to each other and to medications from other classes, the efficacy of specific medications for different subtypes of aggression, combining various psychotropic medications, optimal dosages, and long-term safety.",
keywords = "Aggression, Antipsychotics, Psychosocial treatments",
author = "Schur, {Sarah B.} and Lin Sikich and Findling, {Robert L} and Malone, {Richard P.} and Crismon, {M. Lynn} and Albert Derivan and MacIntyre, {James C.} and Elizabeth Pappadopulos and Laurence Greenhill and Nina Schooler and {Van Orden}, Kimberly and Jensen, {Peter S.}",
year = "2003",
month = "2",
doi = "10.1097/00004583-200302000-00007",
language = "English (US)",
volume = "42",
pages = "132--144",
journal = "Journal of the American Academy of Child and Adolescent Psychiatry",
issn = "0890-8567",
publisher = "Elsevier Limited",
number = "2",

}

TY - JOUR

T1 - Treatment Recommendations for the Use of Antipsychotics for Aggressive Youth (TRAAY). Part I

T2 - A review

AU - Schur, Sarah B.

AU - Sikich, Lin

AU - Findling, Robert L

AU - Malone, Richard P.

AU - Crismon, M. Lynn

AU - Derivan, Albert

AU - MacIntyre, James C.

AU - Pappadopulos, Elizabeth

AU - Greenhill, Laurence

AU - Schooler, Nina

AU - Van Orden, Kimberly

AU - Jensen, Peter S.

PY - 2003/2

Y1 - 2003/2

N2 - Objectives: To review the evidence for the safety and efficacy of nonpharmacological and pharmacological treatments for aggression in children and adolescents. Method: Medline and PsycINFO searches (1990-present) were conducted for double-blind, placebo-controlled studies of atypical antipsychotics for aggression and for literature on the use of other pharmacological agents and psychosocial interventions for aggression. Case reports and adult literature regarding the safety of atypical antipsychotics were used where controlled data for youth were lacking. Results: Controlled data on the treatment of aggression in youth is scarce. Psychosocial interventions may be effective alone or in combination with pharmacological treatments. Psychotropic agents (e.g., stimulants, mood stabilizers, β-blockers) have also been shown to have limited efficacy in reducing aggression. Antipsychotics, particularly the atypical antipsychotics, show substantial efficacy in the treatment of aggression in selected pediatric populations. Atypical antipsychotics are generally associated with fewer extrapyramidal symptoms than are typical antipsychotics. Conclusions: Psychosocial interventions and atypical antipsychotics are promising treatments for aggression in youth. Double-blind studies should examine the safety and efficacy of atypical antipsychotics compared to each other and to medications from other classes, the efficacy of specific medications for different subtypes of aggression, combining various psychotropic medications, optimal dosages, and long-term safety.

AB - Objectives: To review the evidence for the safety and efficacy of nonpharmacological and pharmacological treatments for aggression in children and adolescents. Method: Medline and PsycINFO searches (1990-present) were conducted for double-blind, placebo-controlled studies of atypical antipsychotics for aggression and for literature on the use of other pharmacological agents and psychosocial interventions for aggression. Case reports and adult literature regarding the safety of atypical antipsychotics were used where controlled data for youth were lacking. Results: Controlled data on the treatment of aggression in youth is scarce. Psychosocial interventions may be effective alone or in combination with pharmacological treatments. Psychotropic agents (e.g., stimulants, mood stabilizers, β-blockers) have also been shown to have limited efficacy in reducing aggression. Antipsychotics, particularly the atypical antipsychotics, show substantial efficacy in the treatment of aggression in selected pediatric populations. Atypical antipsychotics are generally associated with fewer extrapyramidal symptoms than are typical antipsychotics. Conclusions: Psychosocial interventions and atypical antipsychotics are promising treatments for aggression in youth. Double-blind studies should examine the safety and efficacy of atypical antipsychotics compared to each other and to medications from other classes, the efficacy of specific medications for different subtypes of aggression, combining various psychotropic medications, optimal dosages, and long-term safety.

KW - Aggression

KW - Antipsychotics

KW - Psychosocial treatments

UR - http://www.scopus.com/inward/record.url?scp=0037318271&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037318271&partnerID=8YFLogxK

U2 - 10.1097/00004583-200302000-00007

DO - 10.1097/00004583-200302000-00007

M3 - Article

C2 - 12544173

AN - SCOPUS:0037318271

VL - 42

SP - 132

EP - 144

JO - Journal of the American Academy of Child and Adolescent Psychiatry

JF - Journal of the American Academy of Child and Adolescent Psychiatry

SN - 0890-8567

IS - 2

ER -